Literature DB >> 4850262

A pharmacological study of the adrenergic mechanisms involved in the stretch reflex of the decerebrate rat.

J W Commissiong, E M Sedgwick.   

Abstract

1 The effects of catecholamine precursors, enzyme inhibitors, and monoamine depletors have been studied on the stretch reflex in the decerebrate rat.2L-DOPA alone had a biphasic effect, facilitation followed by inhibition and recovery of the reflex.3 About 10% of the preparations did not develop decerebrate rigidity. These preparations did not have a stretch reflex. Within 1 to 5 min of the injection of L-DOPA in these inactive preparations, a stretch reflex could be elicited.4 Control experiments indicate that L-DOPA was acting centrally after decarboxylation.5DL-dihydroxyphenylserine had an inhibitory effect, without a preceding facilitation.6 When L-DOPA was preceded by diethyldithiocarbamate (i.v.) or FLA-63 (i.p.), the predominant response was a sustained facilitation, without an accompanying inhibition.7 It is concluded that in the decerebrate rat, increased stretch reflex activity is associated with increased central levels of dopamine, and decreased stretch reflex activity with increased central levels of noradrenaline. The results are discussed with reference to the possibility that dopamine acts by liberating 5-hydroxytryptamine.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4850262      PMCID: PMC1776689          DOI: 10.1111/j.1476-5381.1974.tb09611.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

1.  EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM.

Authors:  K FUXE
Journal:  Acta Physiol Scand Suppl       Date:  1965

2.  Action of 3-hydroxytyramine and some tryptamine derivatives on spinal neurones.

Authors:  D R CURTIS
Journal:  Nature       Date:  1962-04-21       Impact factor: 49.962

3.  Monoamine changes in the brain of rats injected with L-5-hydroxytryptophan.

Authors:  F Okada; Y Saito; T Fujieda; I Yamashita
Journal:  Nature       Date:  1972-08-11       Impact factor: 49.962

Review 4.  Multiple forms of monoamine oxidase: functional significance.

Authors:  M Sandler; M B Youdim
Journal:  Pharmacol Rev       Date:  1972-06       Impact factor: 25.468

Review 5.  Drug therapy of parkinsonism.

Authors:  M D Yahr; R C Duvoisin
Journal:  N Engl J Med       Date:  1972-07-06       Impact factor: 91.245

6.  Multiple forms of monoamine oxidase. Comparison of in vitro and in vivo inhibition patterns.

Authors:  G G Collins; M B Youdim; M Sandler
Journal:  Biochem Pharmacol       Date:  1972-07-15       Impact factor: 5.858

7.  On the descending 5-hydroxytryptaminergic pathway controlling the stretch reflex.

Authors:  P H Ellaway; J E Pascoe; J R Trott
Journal:  J Physiol       Date:  1973-04       Impact factor: 5.182

8.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

Review 9.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

10.  A new dopamine- -hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord.

Authors:  N E Andén; K Fuxe
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

View more
  2 in total

1.  α-adrenoceptor blocking drugs, pressor responses to noradrenaline, and the ankle jerk in man.

Authors:  C De B White; A Richens
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

2.  Neurophysiological basis of functional recovery in the neonatal spinalized rat.

Authors:  J W Commissiong; Y Sauve
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.